Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Common racehorse drug could raise risk of sudden death
The scientists identified a significant risk factor associated with horses being given furosemide on race day.
Researchers conduct the first-ever large-scale study of Thoroughbred racing fatalities.

Researchers have discovered that a common drug used in Thoroughbred racehorses could increase the risk of sudden death.

The first-of-its-kind study analysing data from more than four million starts in horse racing across the USA and Canada found that around one in 10,000 resulted in a race-day sudden death.

Scientists identified a significant risk factor associated with the horses being given furosemide on race day. Horses given the drug were 62 per cent more likely to die suddenly, when compared with horses not given furosemide. 

Furosemide is widely used in the US on race days to prevent pulmonary bleeding and is associated with enhanced racing performance. Consequently, 94 per cent of horse starts in the study had been administered with the drug.
 
Scientists discovered that it could also be possible to identify horses at risk of sudden death before they experience it – for example, due to previous injury and interruption to training. Other risk factors highlighted by the study were horse age and sex, season, purse of race and race distance.

Study author Dr Euan Bennet, from the University of Glasgow's School of Biodiversity, One Health and Veterinary Medicine, commented: “This study suggests that a risk profile, identifying which horses are at the greatest risk of sudden death, may be possible. Given how rare the outcome is, further work is required to establish any potential interventions which might contribute to a reduction in sudden deaths. 

“On the association between furosemide use and sudden death, the fact that furosemide use is so common makes this result particularly remarkable given the statistical power of this large-scale study. Discussions around the ethics of race day administration of drugs should factor in potential risks such as those identified here, and further work is required to understand exactly why we identified this association.”

The study, ‘Fifteen risk factors associated with sudden death in Thoroughbred racehorses in North America (2009-2021),’ is published in the
Journal of the American Veterinary Medicine Association. 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
NSA webinar explores sheep tailing and castration

The National Sheep Association (NSA) is to host a free webinar on the castration and tail docking of lambs.

The webinar, 'Understanding the tailing and castration consultation: A guide for sheep farmers', will be hosted online on Monday, 2 March 2026 at 7.30pm.

It comes during a government consultation into the methods used for these procedures. Farmers are encouraged to engage before the consultation period closes on Monday, 9 March 2026.

The webinar offers clear and actionable guidance to support farmers to contribute meaningfully to the consultation and prepare for potential changes.

On the panel will be former SVS president Kate Hovers, farmer and vet Ann Van Eetvelt and SRUC professor in Animal Health and Veterinary Sciences Cathy Dwyer. Each panel member will utilise their own specialism and expertise to evaluate risks and outcomes to sheep farming.

Find out more about the webinar on the NSA website.